Skin Diseases  >>  Erbitux (cetuximab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Erbitux (cetuximab) / Eli Lilly, EMD Serono
NCT01451632: A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
1
48
US
MM-121, Seribantumab, SAR256212, Irinotecan, Camptosar, Cetuximab, Erbitux
Merrimack Pharmaceuticals, Sanofi
Colorectal Cancer, Squamous Cell Head and Neck Cancer, Non-small Cell Lung Cancer, Triple Negative Breast Cancer, Other Tumors With EGFR Dependence
11/13
06/14

Download Options